title: Medication overuse headaches.
abstract: “An ounce of prevention is worth a pound of cure” in the management of MOH. Prevention of transformation of primary headache types to their chronic counterparts is necessary to prevent this most troubling transformation. Strict attention to what patients are telling you (and often times not telling you) about their episodic headaches will enable pharmacologic and nonpharmacologic measures to avoid that transformation to chronic daily headache, so often associated with MOH. Once MOH becomes manifest, withdrawal of the overused drug is mandatory; otherwise experience tells us the pattern of overuse will only be perpetuated and no measure will help alleviate the headache. At the same time, as detoxification takes place, measures to ensure that relapse will not take place should begin. These efforts include prophylactic pharmacologic measures as well as psychological support, education, and surveillance to prevent relapses. The rate of relapse is unfortunately high, but these general and specific measures enumerated above will add greatly to the chances of success.
authors: Department of Neurology, University of Missouri-Kansas City, School of Medicine, Kansas City, MO 64106, USA. babrams@kc.rr.com
authors: Bernard M
authors: BM
authors: Abrams
mesh_terms: D000700:Analgesics / Q000009:adverse effects; D003937:Diagnosis, Differential; D004876:Ergot Alkaloids / Q000009:adverse effects; D020773:Headache Disorders / Q000150:complications; D051271:Headache Disorders, Secondary / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D008881:Migraine Disorders / Q000150:complications; D013375:Substance Withdrawal Syndrome; D014363:Tryptamines / Q000009:adverse effects
chemical_list: D000700:Analgesics; D004876:Ergot Alkaloids; D014363:Tryptamines